Recombinant Human IL-2 Protein (RMPP-00230030)
Cat. No.: RMPP-00230030
Category: Recombinant Protein
Research Area: Cardiovascular
INQUIRY
10 μg
Customer Size
Product Features
| Purity | > 70% HPLC. 70 - 90% by HPLC |
|---|---|
| Nature | Synthetic |
| Animal Free | No |
| Form | Liquid |
| Applications | Blocking |
| Application Note | Blocking - Blocking peptide for Anti-Jagged1 antibody |
| Key Features | Purity: > 70% HPLC; Suitable for: Blocking |
Protein Information
| UniProt ID | P78504 |
|---|---|
| Sequence Similarities | Contains 1 DSL domain. Contains 15 EGF-like domains. |
| Cellular Localization | Membrane. |
| Tissue Specificity | Widely expressed in adult and fetal tissues. In cervix epithelium expressed in undifferentiated subcolumnar reserve cells and squamous metaplasia. Expression is up-regulated in cervical squamous cell carcinoma. Expressed in bone marrow cell line HS-27a which supports the long-term maintenance of immature progenitor cells. |
| Developmental Stage | Expressed in 32-52 days embryos in the distal cardiac outflow tract and pulmonary artery, major arteries, portal vein, optic vesicle, otocyst, branchial arches, metanephros, pancreas, mesocardium, around the major bronchial branches, and in the neural tube. |
| Function | Ligand for multiple Notch receptors and involved in the mediation of Notch signaling. May be involved in cell-fate decisions during hematopoiesis. Seems to be involved in early and late stages of mammalian cardiovascular development. Inhibits myoblast differentiation (By similarity). Enhances fibroblast growth factor-induced angiogenesis (in vitro). |
| Involvement in Disease | Defects in JAG1 are the cause of Alagille syndrome type 1 (ALGS1). Alagille syndrome is an autosomal dominant multisystem disorder defined clinically by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems.Defects in JAG1 are a cause of tetralogy of Fallot (TOF). TOF is a congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. This condition results in a blue baby at birth due to inadequate oxygenation. Surgical correction is emergent. |
Storage & Shipping
| Shipping and Storage | Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. Information available upon request. |
|---|
For research use only. Not for clinical use.
